Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 72Colorectal Neoplasms 43Rectal Neoplasms 41Stomach Neoplasms 38Triple Negative Breast Neoplasms 30Neoplasm Metastasis 19Esophageal Neoplasms 16Colonic Neoplasms 16Pancreatic Neoplasms 12Parkinson Disease 4, Autosomal Dominant Lewy Body 11Neoplasms 11Nasopharyngeal Carcinoma 11Adenocarcinoma 11Biliary Tract Neoplasms 10Adenocarcinoma Of Esophagus 9Cholangiocarcinoma 7Locally Advanced Rectal Cancer 6Esophageal Squamous Cell Carcinoma 6Brain Neoplasms 6Anus Neoplasms 6Recurrence 5Gastrointestinal Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Neuroendocrine Tumors 4HER2-positive Breast Cancer 4Colorectal Cancer Metastatic 4Carcinoma, Non-Small-Cell Lung 4Carcinoma, Hepatocellular 4Pathologic Complete Response 3Ovarian Neoplasms 3

Interventions

Blood Specimen Collection 5pembrolizumab 2fluciclovine F-18 2Surveys and Questionnaires 2Preoperative Exercise 2Magnetic Resonance Imaging 2Exercise 2Cryosurgery 2Bevacizumab 2tislelizumab 1neratinib 1imetelstat 1daratumumab 1atezolizumab 1abiraterone 1Waiting Lists 1Videotape Recording 1Urine Specimen Collection 1Transcutaneous Electric Nerve Stimulation 1Tomography, X-Ray Computed 1Thoracic Surgical Procedures 1TIC10 compound 1Sulfonylurea Compounds 1Standard of Care 1Specimen Handling 1Sodium-Glucose Transporter 2 Inhibitors 1Serologic Tests 1Sequence Analysis, RNA 1S-Adenosylmethionine 1Referral and Consultation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Disease × Capecitabine × 1 year × Clear all
NCT07134101 2025-08-29

SMARTi-RC01

The First Affiliated Hospital with Nanjing Medical University

Phase 2 Not yet recruiting
138 enrolled
Gastrointestinal

Disease, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡